Total Payments
$345,339
2024 Payments
$59,629
Companies
43
Transactions
1,223
Medicare Patients
2,720
Medicare Billing
$481,746
Payment Breakdown by Category
Other$237,090 (68.7%)
Consulting$51,454 (14.9%)
Travel$28,964 (8.4%)
Food & Beverage$25,602 (7.4%)
Education$2,229 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $237,090 | 116 | 68.7% |
| Consulting Fee | $51,454 | 42 | 14.9% |
| Travel and Lodging | $28,964 | 79 | 8.4% |
| Food and Beverage | $25,602 | 981 | 7.4% |
| Education | $2,229 | 5 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $188,406 | 192 | $0 (2024) |
| EKOS Corporation | $61,785 | 75 | $0 (2019) |
| Baxter Healthcare | $38,791 | 17 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $26,209 | 264 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $12,300 | 53 | $0 (2024) |
| Amgen Inc. | $4,214 | 16 | $0 (2024) |
| GlaxoSmithKline, LLC. | $3,217 | 253 | $0 (2024) |
| Access Vascular Inc | $2,238 | 1 | $0 (2022) |
| Acerta Pharma LLC | $1,966 | 2 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $987.58 | 51 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $59,629 | 187 | Boston Scientific Corporation ($53,932) |
| 2023 | $57,534 | 178 | Boston Scientific Corporation ($51,283) |
| 2022 | $78,702 | 175 | Baxter Healthcare ($31,896) |
| 2021 | $55,943 | 103 | BOSTON SCIENTIFIC CORPORATION ($41,340) |
| 2020 | $24,313 | 58 | Boston Scientific Corporation ($17,250) |
| 2019 | $47,437 | 214 | EKOS Corporation ($44,540) |
| 2018 | $17,919 | 178 | EKOS Corporation ($15,565) |
| 2017 | $3,862 | 130 | EKOS Corporation ($1,679) |
All Payment Transactions
1,223 individual payment records from CMS Open Payments — Page 1 of 49
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Boston Scientific Corporation | — | Consulting Fee | Cash or cash equivalent | $1,562.50 | General |
| Category: Clinical Trial Product_PI | ||||||
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Respiratory | ||||||
| 12/19/2024 | Boston Scientific Corporation | EkoSonic (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $312.50 | General |
| Category: EkoSonic_PI | ||||||
| 12/19/2024 | Boston Scientific Corporation | EkoSonic (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $312.50 | General |
| Category: EkoSonic_PI | ||||||
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Respiratory | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Respiratory | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: NEUROLOGY | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: CRITICAL CARE | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $33.51 | General |
| Category: RESPIRATORY | ||||||
| 11/22/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $8.27 | General |
| Category: NEUROLOGY | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $81.27 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | Boston Scientific Corporation | — | Consulting Fee | Cash or cash equivalent | $78.13 | General |
| Category: Clinical Trial Product_PI | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: RESPIRATORY | ||||||
| 11/16/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Pulmonology | ||||||
| 11/14/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $4.83 | General |
| Category: Narcoplepsy | ||||||
| 11/13/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $4.83 | General |
| Category: Narcoplepsy | ||||||
| 11/13/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $2.58 | General |
| Category: Narcoplepsy | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 616 | 911 | $494,414 | $104,556 |
| 2022 | 16 | 759 | 1,094 | $499,560 | $117,795 |
| 2021 | 15 | 733 | 1,190 | $466,038 | $131,844 |
| 2020 | 11 | 612 | 999 | $335,974 | $127,551 |
Total Patients
2,720
Total Services
4,194
Medicare Billing
$481,746
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 148 | 352 | $295,895 | $62,824 | 21.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 51 | 121 | $11,550 | $5,047 | 43.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 50 | $15,330 | $4,843 | 31.6% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 67 | 67 | $37,200 | $4,751 | 12.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 73 | $15,800 | $4,713 | 29.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $12,365 | $3,832 | 31.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 24 | 24 | $10,725 | $3,519 | 32.8% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 37 | 37 | $29,019 | $3,457 | 11.9% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 33 | 35 | $38,840 | $3,253 | 8.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 22 | $5,325 | $2,214 | 41.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $5,760 | $2,051 | 35.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 26 | $4,340 | $1,739 | 40.1% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 21 | 21 | $4,470 | $989.84 | 22.1% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 20 | 20 | $3,190 | $684.90 | 21.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 21 | 21 | $4,605 | $639.92 | 13.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 172 | 367 | $275,100 | $67,090 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 70 | 93 | $19,740 | $6,367 | 32.3% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 62 | 62 | $47,269 | $6,186 | 13.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 54 | $16,610 | $5,701 | 34.3% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2022 | 60 | 61 | $34,090 | $4,429 | 13.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 40 | 51 | $13,285 | $4,210 | 31.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 23 | 24 | $12,190 | $4,028 | 33.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 57 | 124 | $12,035 | $3,986 | 33.1% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 34 | 38 | $13,545 | $3,526 | 26.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 25 | 25 | $10,775 | $3,173 | 29.5% |
About Dr. Patrick Troy, MD
Dr. Patrick Troy, MD is a Internal Medicine healthcare provider based in Hartford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1033255229.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Troy, MD has received a total of $345,339 in payments from pharmaceutical and medical device companies, with $59,629 received in 2024. These payments were reported across 1,223 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($237,090).
As a Medicare-enrolled provider, Troy has provided services to 2,720 Medicare beneficiaries, totaling 4,194 services with total Medicare billing of $481,746. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Sleep Medicine
- Location Hartford, CT
- Active Since 01/29/2007
- Last Updated 04/01/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1033255229
Products in Payments
- EkoSonic (Device) $122,709
- EKOSONIC (Device) $65,532
- Renal - CRRT (Device) $22,970
- TEZSPIRE (Biological) $21,413
- AngioJet Ultra 5000A (Device) $11,675
- XYWAV (Drug) $10,178
- STARLING SYSTEM (Device) $10,015
- GENERAL - THERAPIES (Device) $9,000
- GENERAL - VASCULAR INTERVENTION (Device) $8,250
- GENERAL VASCULAR INTERVENTION (Device) $7,000
- AngioJet (Device) $4,729
- General - Vascular Intervention (Device) $4,500
- HYDROPICC (Device) $2,238
- GENERAL THERAPIES (Device) $1,979
- Non-Franchise (NOF) - NonProduct (Biological) $1,825
- TRELEGY ELLIPTA (Drug) $1,718
- XYREM (Drug) $1,654
- CLINICAL TRIAL PRODUCT (Device) $1,375
- ANGIOJET (Device) $1,191
- FASENRA (Biological) $1,166
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Hartford
Dr. Jeffrey Nascimento, D.o, D.O
Internal Medicine — Payments: $208,690
Internal Medicine $208,690
Dr. Stephanie Saucier, Md, MD
Internal Medicine — Payments: $133,282
Internal Medicine $133,282
Antonio Fernandez, Md, MD
Internal Medicine — Payments: $88,033
Internal Medicine $88,033
Adam Boruchov, Md, MD
Internal Medicine — Payments: $80,937
Internal Medicine $80,937
Eric Crespo, M.d, M.D
Internal Medicine — Payments: $76,431
Internal Medicine $76,431
Dr. Anil Magge, M.d, M.D
Internal Medicine — Payments: $46,337
Internal Medicine $46,337